Document:

Exhibit

Exhibit 10.27

GUARANTEE AGREEMENT

This GUARANTEE AGREEMENT (this “Agreement”), dated as of January 1, 2017, is entered into by and among Watford Specialty Insurance Company, a New Jersey domiciled excess and surplus lines insurance company (“WSIC”) and Arch Capital Group (U.S.) Inc., a Delaware holding company (“Arch”) indirectly wholly-owned by Arch Capital Group Ltd.  

R E C I T A L S
WHEREAS, WSIC and Arch Underwriters Inc. (“AUI”) are party to a services agreement dated October 1, 2016 (as amended from time to time, the “Services Agreement”);
WHEREAS, Arch is willing to guarantee the performance of AUI under the Services Agreement;
WHEREAS, each of WSIC and Arch has all the requisite authority to enter into and perform this Agreement;
NOW THEREFORE, in consideration of the mutual covenants and agreements herein and for other good and valuable consideration the receipt and sufficiency whereof is hereby acknowledged, the parties hereto agree as follows:
1.Performance Guarantee.  Arch hereby unconditionally and irrevocably guarantees to WSIC the full and punctual performance by AUI of all of its obligations under the Services Agreement (“Obligations”).  Should AUI default in the performance of any of its Obligations, WSIC may cause, by notice to Arch, the immediate performance by Arch (or its designee) of the Obligations.  Arch’s obligations hereunder shall remain in full force and effect until all Obligations have been fully performed and satisfied in full.
2.Miscellaneous.
a.  This Agreement contains the entire understanding between the Parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings between the Parties relating to the subject matter hereof, and each Party hereto agrees that each and every such prior agreement and understanding is terminated and replaced in its entirety by the rights created by this Agreement.
b.  This Agreement will be binding upon and inure to the benefit of the Parties hereto and their respective successors and permitted assigns.  Notwithstanding the foregoing, neither Party may pledge, assign, transfer, subcontract or delegate, either in whole or in part, its right and obligations under this Agreement without the prior written consent of the other Party.  
c.  The Parties recognize and agree that if for any reason any of the provisions of this Agreement are not performed in accordance with their specific terms or are otherwise breached, immediate and irreparable harm or injury would be caused for which money damages would not be an adequate remedy.  Accordingly, each Party agrees that, in addition to any other available remedies, the other Party shall be entitled to an injunction restraining any violation or threatened violation of any of the provisions of this Agreement without the necessity of posting a bond or other form of security.  In the event that any action 

should be brought in equity to enforce any of the provisions of this Agreement, neither Party will allege, and each Party hereby waives the defense, that there is an adequate remedy at law. 
d.  Any notice, direction, instruction, acknowledgment or other communication required or contemplated by this Agreement will be in writing and addressed to the parties as follows:

If to WSIC:
445 South Street, Suite 220
P. O. Box 1988
Morristown, NJ  07962-1988
Attention:  Alexandre Scherer, President & CEO 
Telephone No.: 1-973-753-1331

If to Arch:
Arch Capital Group (U.S.) Inc.
Harborside 3 
210 Hudson Street, Suite 300
Jersey City, NJ  07311-1107
Attention:  Thomas Ahern, Senior Vice President & CFO
Telephone No.:  1-201-743-4047

e.  This Agreement is to be governed by, and construed in accordance with, the laws of the State of New Jersey, without giving effect to its conflict of laws principles.

f.  No assignment, amendment, modification, or termination shall be effective unless such assignment, amendment, modification, or termination is (i) filed with the New Jersey Department of Banking and Insurance (“NJDOBI”) at least 30 days prior to the proposed effective date, (ii) not disapproved by the NJDOBI, (iii) made in writing, and (iv) signed by the parties hereto.

g.  Any dispute or claim arising out of or relating to this Agreement, including its formation and validity, shall be referred to arbitration.  Arbitration shall be initiated by the delivery, by mail, facsimile, email or other reliable means, of a written demand for arbitration by one party to the other.  The arbitration shall be held in New York, New York or such other place as the parties may mutually agree.  Arbitration shall be conducted before a three-person arbitration panel (the “Arbitration Panel”) selected by mutual agreement of the Parties or, failing such agreement, pursuant to the ARIAS U.S. Umpire Selection Procedure.  The arbitrators and Umpire shall be either present or former executive officers of insurance or reinsurance companies or arbitrators certified by ARIAS U.S.  The arbitrators and Umpire shall not be under the control of either party, and shall have no financial interest in the outcome of the arbitration.  The arbitrators and Umpire shall not be obligated to follow the strict rules of evidence.  The decision of a majority of the Arbitration Panel shall be final and binding to the fullest extent permitted by law.  The Arbitration Panel shall render its award in writing.  Judgment upon the award may be entered in any court having jurisdiction.  Unless the Arbitration Panel orders otherwise, each party shall pay an equal share of the fees and expenses of the arbitrators and of the other expenses of the arbitration.  Notwithstanding anything to the contrary in this Agreement, if a final and binding decision has been rendered in an arbitration under the Services Agreement with respect to an action or dispute arising under 

the Services Agreement, then such final and binding decision shall be accepted by the Parties in lieu of any separate arbitration pursuant to this clause (f) based on the same or substantially similar facts.  For avoidance of doubt (i) if such decision is in favor of Arch or any affiliate of Arch, WSIC will not be entitled to make or pursue a guarantee claim under this Agreement that is inconsistent with such final and binding decision.

h.  Arch shall not effect any consolidation or merger with another company in which Arch is not the survivor, or any sale, transfer or other disposition of all or substantially all of Arch’s assets to another company unless prior to or simultaneously with the consummation thereof the successor company (if other than Arch) resulting from such consolidation or merger, or the company purchasing or otherwise acquiring such assets or other appropriate company or entity shall assume the obligations of Arch under this Agreement. 

i.  This Agreement may be executed in one or more counterparts, each of which will be deemed an original, but all of which taken together will constitute one and the same instrument.

j.  If any provision of this Agreement will be held or made invalid by a court decision, statue, rule or otherwise, the remainder of this Agreement will not be affected thereby. 

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above. 

	
		
	WATFORD SPECIALTY INSURANCE COMPANY

	 
	 

	 
	 

	By:
	/s/ Alexandre Sherer

	 
	Name: Alexandre Scherer

	 
	Title: President & CEO

	
		
	ARCH CAPITAL GROUP (U.S.) INC.

	 
	 

	 
	 

	By:
	/s/ Thomas Ahern

	 
	Name: Thomas Ahern

	 
	Title: Senior Vice President & CFOEXHIBIT 10.1

 Exhibit 10.1 

Citibank Europe PLC, UK Branch, as Administrative Agent 

for the Lenders party to the Credit Agreement 

referred to below 
 Ladies and Gentlemen: 

Each of the undersigned Lenders (each such Lender, an “Extending Lender”) hereby agrees to extend, effective 5 February
2019, its Commitment and the Maturity Date under the Credit Agreement, dated as of 12 February 2013 (as amended or modified from time to time, the “Credit Agreement,” the terms defined therein being used herein as therein
defined), among Philip Morris International Inc. (“PMI”), the Lenders party thereto and Citibank Europe PLC, UK Branch (legal successor to Citibank International Limited), as Administrative Agent, for an additional 364-day period to 4 February 2020 pursuant to Section 2.19 of the Credit Agreement. 
 Effective
5 February 2019 (i) Schedule 4 Revolving Credit Commitments is hereby deleted in its entirety and is replaced with Schedule 4 Revolving Credit Commitments attached hereto subject to the addition of one or more Assuming Lenders prior to the
Maturity Date, provided that total aggregate Revolving Credit Commitments shall in no event exceed $2,000,000,000, and (ii) Subsection (a)(i)(A) of Section 2.19 of the Credit Agreement is hereby amended in its entirety to read as follows
“(A) provides written notice requesting the extension to the Administrative Agent not less than 25 days and not more than 60 days prior to the Maturity Date and”. 

Except as expressly provided hereby, all of the terms and provisions of the Credit Agreement are and shall remain in full force and effect and
are hereby ratified and confirmed. 
 This Extension Agreement shall be governed by, and construed in accordance with, the laws of the State
of New York. This Extension Agreement may be signed in any number of counterparts, each of which when executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. 

[Signature pages omitted]EX-10.1

 Exhibit 10.1 

January 28, 2019 
 PERSONAL AND CONFIDENTIAL 

Troy Ignelzi 
 Re:    Separation
Agreement 
 Dear Troy: 
 This letter confirms your
separation from employment with scPharmaceuticals Inc. (the “Company”). This letter also proposes an agreement between you and the Company during which you would remain employed for a transitional period and then receive severance
benefits. Your separation shall be effective February 28, 2019, unless you resign without “Good Reason” (as defined in your Employment Agreement with the Company dated November 16, 2017 (the “Employment Agreement”)) or
unless the Company terminates your employment for “Cause” (as defined in the Employment Agreement) prior to that date. The actual last day of your employment with the Company, whether February 28, 2019 or an earlier date as provided
in the preceding sentence, is the “Separation Date.” 
 Regardless of whether you enter into this Agreement (as defined below), the Company shall
pay you your “Accrued Benefit” under Section 4(a) of your Employment Agreement on or after the Separation Date, within the period required by law. Your Accrued Benefit consists of (i) your salary, unused vacation, and
properly documented expenses (the latter subject to Section 2(c) of the Employment Agreement), in each case accrued to you but unpaid as of the Separation Date, and (ii) any vested benefits you may have under any employee
benefit plan of the Company through the Separation Date, which vested benefits shall be paid and/or provided in accordance with the terms of such employee benefit plans. You also shall be provided with the opportunity to continue group health
coverage after the Separation Date under the law known as “COBRA,” if you are eligible for COBRA, at your own sole expense. 
 You are subject to
continuing obligations under Sections 7 (“Confidential Information, Noncompetition and Cooperation”) and 8 (“Arbitration of Disputes”) of the Employment Agreement, which include without limitation your obligation to refrain from
competing with the Company and from soliciting Company employees and customers, in each case for the 12 months following the Separation Date, refrain from disclosing Company confidential information at any time, and return all Company property to
the Company on or before the Separation Date (collectively with any other confidentiality and/or restrictive covenant obligation you have to the Company or any Company affiliate, the “Ongoing Obligations”). The Ongoing Obligations remain
in full effect in accordance with their terms. 
 Any stock options that you have shall be governed in all respects by (i) each incentive stock
option agreement or non-qualified stock option agreement, as applicable, identified in Section 2 and (ii) the scPharmaceuticals Inc. 2014 Stock Incentive Plan and the scPharmaceuticals Inc. 2017 Stock Option and Incentive
Plan, as applicable ((i) and (ii) collectively, the “Equity Documents”)), except as otherwise expressly provided below. 

  
 1 

 The remainder of this letter proposes an agreement (the “Agreement”) between you and the Company.
You and the Company agree as follows: 
  

	(1)	 Severance Benefits. Provided that (i) you do not resign without Good Reason and are not
terminated for Cause prior to February 28, 2019 and (ii) within the seven-day period immediately following the Separation Date, you sign and return the Certificate attached as Exhibit
A: 

  

	a)	 Severance Pay. The Company shall pay you severance pay (“Severance Pay”) consisting of salary
continuation of six (6) months of your base salary rate in effect on the Separation Date. In addition, if as of the date that is six (6) months following the Separation Date, you have not entered into any Service Relationship (as defined
below), the Company shall pay you up to an additional three (3) months of salary continuation at your final base salary rate for so long as you have not entered into any Service Relationship over the following three-month period. The
total period during which the salary continuation is paid is the “Severance Pay Period.” The Company shall pay you Severance Pay in installments on its regular payroll dates applicable to your position with the Company, beginning on the
first applicable payroll date after the Certificate Effective Date (as defined in Exhibit A). A “Service Relationship” means any employment, independent contractor, consulting, director or other position for which you perform services of
any nature in exchange for compensation of any kind (whether cash, equity or otherwise and including any deferred compensation arrangement). 

  

	b)	 Health Benefits. If you are eligible for and elect COBRA continuation coverage, the Company shall pay
the same portion of premiums that it pays for active employees for the same level of group health coverage as in effect on the Separation Date, such payments to commence in respect of COBRA continuation coverage beginning on March 1, 2019, with
such payments continuing thereafter until the earlier of the end of (x) the Severance Pay Period or (y) your eligibility under COBRA for continuation coverage for group health care. You will be responsible for paying the
remaining portion of the premiums for such coverage as if you remained employed. You authorize the deduction of the portion for which you are responsible from your Severance Pay. 

 

	(2)	 Extension of Exercise Period 

In accordance with the vesting schedules set forth in (i) your incentive stock option agreements dated (a) March 16, 2016, (b)
April 17, 2017 and (c) January 17, 2018 and (ii) your non-qualified stock option agreements dated (x) March 16, 2016, (y) April 17, 2017 and
(z) January 17, 2018, as of the date of this Agreement your options to purchase up to 81,958 shares of the Company’s common stock (“Shares”) are vested (the “Vested Option”), and your options to
purchase up to 84,824 Shares are unvested (the “Unvested Option”). Your Unvested Option will continue to vest until the Separation Date, in accordance with and subject to the Equity Documents. Pursuant to the terms of the Equity Documents,
you will have ninety (90) days from the Separation Date (the “Exercise Period”) to exercise your right to purchase up to the number of shares subject to the Vested Option (which shall be updated to include any option vesting
between the date of this Agreement and the Separation Date). If you enter into and comply with this Agreement, the Exercise Period with respect to the Vested Option shall be extended until 24 months after the Separation Date (the
“Extension”). The shares subject to the Unvested Option (which shall be updated to include any option vesting between the date of this Agreement and the Separation Date) shall expire and become null and void as of the Separation Date. 

  
 2 

 You acknowledge that as a result of the Extension, your options that are incentive stock options presently
will convert to nonqualified stock options, consistent with the Equity Documents and applicable law. You are advised to seek tax guidance from your personal tax advisors with regard to the potential change in tax treatment of your vested options (if
they are incentive stock options presently) if you agree to the extension of the Exercise Period. The Equity Documents shall otherwise be in full force and effect. Except as expressly provided herein with respect to the Extension, in the event of
any conflict between the Equity Documents and this Agreement, the Equity Documents shall control. 
  

	(3)	 Release of Claims 

In consideration for, among other terms, your transitional period of employment hereunder, the Severance Pay and the Extension, to each of which you
acknowledge you would otherwise not be entitled, you voluntarily release and forever discharge the Company, its affiliated and related entities, its and their respective predecessors, successors and assigns, its and their respective employee benefit
plans and fiduciaries of such plans, and the current and former officers, directors, shareholders, employees, attorneys, accountants and agents of each of the foregoing in their official and personal capacities (collectively referred to as the
“Releasees”) generally from all claims, demands, debts, damages and liabilities of every name and nature, known or unknown (“Claims”) that, as of the date when you sign this Agreement, you have, ever had, now claim to have or
ever claimed to have had against any or all of the Releasees. This release includes, without limitation, all Claims: 
  

	•	 	 relating to your employment by the Company and the decision to terminate your employment with the Company;

  

	•	 	 of wrongful discharge or violation of public policy; 

 

	•	 	 of breach of contract; 

 

	•	 	 of defamation or other torts; 

 

	•	 	 of retaliation or discrimination under federal, state or local law 

 

	•	 	 under any other federal or state statute, including without limitation the Massachusetts Pay Equity Law;

  

	•	 	 under the Age Discrimination in Employment Act; 

 

	•	 	 for wages, bonuses, expense reimbursements, the payment of expenses, incentive compensation, expenses,
commissions, overtime, stock, stock options, severance pay, vacation pay or any other compensation or benefits, either under the Massachusetts Wage Act, M.G.L. c. 149, §§148-150C, under M.G.L. c.
151, or otherwise; and 

  

	•	 	 for damages or other remedies of any sort, including, without limitation, compensatory damages, punitive damages,
injunctive relief and attorney’s fees; provided, however, that this release shall not affect your rights under this Agreement and to any vested benefits under any 401(k) plan. 

  
 3 

 You agree not to accept damages of any nature, other equitable or legal remedies for your own benefit or
attorney’s fees or costs from any of the Releasees with respect to any Claim released by this Agreement. As a material inducement to the Company to enter into this Agreement, you represent that you have not assigned any Claim to any third
party. 
 You acknowledge and agree that except as expressly specified in this Agreement, you are not entitled to any wages, salary, vacation pay, bonuses,
severance, equity (including without limitation any equity acceleration) or any other compensation or benefits from the Company or any of its affiliates. 
  

	(4)	 Nondisparagement 

You agree not to make any disparaging statements, whether verbally, in writing, on social media or otherwise, concerning the Company or any of its affiliates
or current or former officers, directors, shareholders, employees, other agents, products or services. These nondisparagement obligations shall not in any way affect your obligation to testify truthfully in any legal proceeding. 

 

	(5)	 Confidentiality of Agreement-Related Information 

You agree, to the fullest extent permitted by law, to keep all information related to this Agreement confidential to the extent not publicly disclosed by the
Company. Notwithstanding the foregoing, you may disclose Agreement-Related Information to your spouse, your attorney and your financial advisors, and to them only provided that they first agree for the benefit of the Company to keep
Agreement-Related Information confidential. 
  

	(6)	 Return of Property 

You confirm that, to the best of your knowledge, you have returned to the Company all Company property, including, without limitation, computer equipment,
software, keys and access cards, credit cards, files and any documents (including computerized data and any copies made of any computerized data or software) containing information concerning the Company, its business or its business relationships.
You also commit to deleting and finally purging any duplicates of files or documents that may contain Company information from any computer or other device that remains your property after the Separation Date. In the event that you discover that you
continue to retain any such property, you shall return it to the Company immediately. 
  

	(7)	 Defend Trade Secrets Act Notice. 

You understand that pursuant to the Defend Trade Secrets Act of 2016, you shall not be held criminally or civilly liable under any federal or state trade
secret law for the disclosure of a trade secret that (A) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of
reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. 

  
 4 

	(8)	 Protected Disclosures. 

Nothing contained in this Agreement limits your ability to file a charge or complaint with any federal, state or local governmental agency or commission (a
“Government Agency”). In addition, nothing contained in this Agreement limits your ability to communicate with any Government Agency or otherwise participate in any investigation or proceeding that may be conducted by any Government
Agency, including your ability to provide documents or other information, without notice to the Company, nor does anything contained in this Agreement apply to truthful testimony in litigation. If you file any charge or complaint with any Government
Agency and if the Government Agency pursues any claim on your behalf, or if any other third party pursues any claim on your behalf, you waive any right to monetary or other individualized relief (either individually, or as part of any collective or
class action), provided that nothing in this Agreement limits any right you may have to receive a whistleblower award or bounty for information provided to the Securities and Exchange Commission. 

 

	(9)	 Other Provisions 

 

	a)	 Termination and Return of Payments. If you breach any of your obligations under this Agreement,
including the Ongoing Obligations, in addition to any other legal or equitable remedies it may have for such breach, the Company shall have the right to terminate its non-wage payments to you or for your
benefit under this Agreement, require the return of such payments, and/or terminate your extended option exercise period. The termination or return of such payments and/or termination of your extended option exercise period in the event of your
breach will not affect your continuing obligations under this Agreement or under the Ongoing Obligations. 

  

	b)	 Enforceability. If any portion or provision of this Agreement (including, without limitation, any
portion or provision of any section of this Agreement) shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in
circumstances other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law. Any breach
of this Agreement by the Company shall not constitute a defense to enforcement of any provision of the Ongoing Obligations. 

  

	c)	 Waiver; Absence of Reliance. No waiver of any provision of this Agreement shall be effective unless made
in writing and signed by the waiving party. The failure of a party to require the performance of any term or obligation of this Agreement, or the waiver by a party of any breach of this Agreement, shall not prevent any subsequent enforcement of such
term or obligation or be deemed a waiver of any subsequent breach. In signing this Agreement, you are not relying upon any promises or representations made by anyone at or on behalf of the Company, except as expressly provided in this Agreement.

  

	d)	 Jurisdiction; Governing Law; Interpretation. You and the Company hereby agree that, to the extent
expressly permitted under Section 8 of the Employment Agreement regarding arbitration, and except as expressly provided in the Ongoing Obligations or the Equity 

  
 5 

	 	
Documents, the state and federal court of Massachusetts located in Boston shall have the exclusive jurisdiction to consider any matters related to this Agreement, including without limitation any
claim of a violation of this Agreement. With respect to any such court action, you submit to the jurisdiction of such courts and you acknowledge that venue in such courts is proper. This Agreement shall be interpreted and enforced under the laws of
Massachusetts, without regard to conflict of law principles. YOU AND THE COMPANY HEREBY WAIVE ANY RIGHT TO TRIAL BY JURY WITH RESPECT TO ANY SUCH COURT ACTION. 

  

	e)	 Entire Agreement. This Agreement constitutes the entire agreement between you and the Company and
supersedes any previous agreements or understandings between you and the Company, including without limitation your Employment Agreement (and specifically including the severance provisions of your Employment Agreement), except the Ongoing
Obligations (which are incorporated herein by reference) and the Equity Documents. 

  

	f)	 Tax Matters. All payments pursuant to this Agreement shall be subject to applicable taxes and
withholdings and each payment pursuant to this Agreement is intended to constitute a separate payment for purposes of Treasury Regulation Section 1.409A-2(b)(2). 

 

	g)	 Time for Consideration; Effective Date. 

You acknowledge that you have been given the opportunity to consider this Agreement for twenty-one
(21) days before signing it (the “Consideration Period”) and that you have knowingly and voluntarily entered into this Agreement. You acknowledge that the above release of claims expressly includes without limitation claims
under the Age Discrimination in Employment Act. You are advised to consult with an attorney before signing this Agreement. To accept this Agreement, you must return a signed original or a signed PDF copy of this Agreement so that it is received by
the undersigned at or before the expiration of the Consideration Period. If you sign this Agreement before the end of the Consideration Period, you acknowledge by signing this Agreement that such decision was entirely voluntary and that you had the
opportunity to consider this Agreement for the entire Consideration Period. For the period of seven (7) days from the date when you sign this Agreement, you have the right to revoke this Agreement by written notice to the undersigned.
For such a revocation to be effective, it must be delivered so that it is received by the undersigned at or before the expiration of the seven (7) day revocation period (the “Revocation Period”). This Agreement shall not become
effective or enforceable during the Revocation Period. It will become effective on the day after the Revocation Period ends (the “Effective Date”). 
  

	h)	 Counterparts. This Agreement may be executed in separate counterparts. When all counterparts are signed,
they shall be treated together as one and the same document. 

 Please indicate your agreement to the terms of this Agreement by signing
and returning to the undersigned the original or a PDF copy of this letter within the time period set forth above. 

  
 6 

 Very truly yours, 

scPharmaceuticals Inc. 
  

							
	By:	 	 /s/ John Tucker

President and CEO
	 	
                   
 
 
 
	  	 1/28/2019

Date

  
 7 

 This is a legal document. Your signature will commit you to its terms. By signing below, you acknowledge
that you have carefully read and fully understand all of the provisions of this Agreement and that you are knowingly and voluntarily entering into this Agreement. 
  

					
	 /s/ Troy Ignelzi

Troy Ignelzi
	  	                    	  	 1/29/2019

Date

  

  
 8 

 EXHIBIT A 

CERTIFICATE UPDATING RELEASE OF CLAIMS 

I, hereby acknowledge and certify that I entered into a Separation Agreement with scPharmaceuticals Inc. (the “Company”), dated
January 28, 2019 (the “Agreement”). Capitalized but undefined terms in this Certificate are defined in the Agreement. Pursuant to the Agreement, I am required to sign this “Certificate,” which updates the release of claims
in the Agreement, in order to receive the severance benefits described in the Agreement. For this Certificate to become effective and for me to receive such severance benefits, I must sign this Certificate after the Separation Date but no later
than seven days after the Separation Date. I will not sign this Certificate before the Separation Date. Subject to the foregoing, the date I sign this Certificate is the “Certificate Effective Date.” I further agree as follows: 

 

	 	1.	 A copy of this Certificate was attached to the Agreement as Exhibit A. 

 

	 	2.	 In consideration of the benefits described in the Agreement, for which I become eligible only if I sign this
Certificate, I hereby extend the release of claims set forth in the Agreement to any and all claims that arose after the date I signed the Agreement through the date I signed this Certificate, subject to all other exclusions and terms set forth in
the Agreement. 

  

	 	3.	 I have carefully read and fully understand all of the provisions of this Certificate, I knowingly and
voluntarily agree to all of the terms set forth in this Certificate, and I acknowledge that in entering into this Certificate, I am not relying on any representation, promise or inducement made by the Company or its officers, directors, employees,
agents or other representatives with the exception of those promises expressly contained in this Certificate and the Agreement. 

  

	 	4.	 I also represent that I have not been subject to any retaliation or any other form of adverse action by the
Releasees for any action taken by me as an employee or resulting from my exercise of or attempt to exercise any statutory rights recognized under federal, state or local law. I agree that I have been paid all wages and other compensation owed to me.
I also agree that and that none of my rights have been violated under any statute, common law or Company policy, program or agreement. I represent that I have reported any and all workplace injuries that I suffered during my employment, if any, to
the Company before executing this Certificate. 

  

	 	5.	 I agree that this Certificate is part of the Agreement. 

Accepted and agreed: 
  

					
	  
 Troy Ignelzi
	  	                    	  	  
 Date

  
 9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00291-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00291-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00291-of-00352.parquet"}]]